Cargando…
Down-Regulation of CEND1 Expression Contributes to The Progression and Temozolomide Resistance of Glioma
OBJECTIVE: This study was conducted to clarify the expression characteristics of cell cycle exit and neuronal differentiation 1 (CEND1) in glioma and its effects on the proliferation, migration, invasion, and resistance to temozolomide (TMZ) of glioma cells. MATERIALS AND METHODS: In this experiment...
Autores principales: | Houjun, Zhou, Peng, Bai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201357/ https://www.ncbi.nlm.nih.gov/pubmed/37210647 http://dx.doi.org/10.22074/CELLJ.2022.557561.1074 |
Ejemplares similares
-
Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells
por: Qiu, Zhi-Kun, et al.
Publicado: (2014) -
Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1
por: Järveläinen, Harri A., et al.
Publicado: (2023) -
Efficacy of inverso isomer of CendR peptide on tumor tissue penetration
por: Wang, Ruifeng, et al.
Publicado: (2018) -
Cend1, a Story with Many Tales: From Regulation of Cell Cycle Progression/Exit of Neural Stem Cells to Brain Structure and Function
por: Gaitanou, Maria, et al.
Publicado: (2019) -
Down-regulation of ABCE1 inhibits temozolomide resistance in glioma through the PI3K/Akt/NF-κB signaling pathway
por: Zhang, Peng, et al.
Publicado: (2018)